Last 7 days
-0.8%
Last 30 days
2.6%
Last 90 days
-11.3%
Trailing 12 Months
-10.5%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
WM | 66.2B | 19.9B | -1.84% | 3.19% | 29.3 | 3.32 | 7.84% | 18.34% |
CTAS | 47.0B | 8.6B | 0.95% | 25.29% | 36.26 | 5.46 | 13.01% | 7.22% |
RSG | 45.1B | 14.1B | 2.43% | 7.15% | 29.7 | 3.2 | 21.02% | 12.77% |
CPRT | 41.2B | 3.7B | 10.07% | 59.89% | 38.09 | 11.22 | 16.24% | -0.79% |
WCN | 35.3B | 7.5B | -3.49% | 8.77% | 41.39 | 4.73 | 16.63% | 33.72% |
MID-CAP | ||||||||
CLH | 7.8B | 5.3B | 0.23% | 62.03% | 17.82 | 1.47 | 27.32% | 93.47% |
TTEK | 7.3B | 3.8B | -1.59% | 9.53% | 23.54 | 1.91 | 12.95% | 25.10% |
CWST | 4.8B | 1.1B | 5.43% | 33.09% | 91.88 | 4.33 | 19.27% | 27.96% |
SRCL | 4.0B | 2.7B | 2.58% | -10.51% | 48.91 | 1.47 | 3.09% | 222.06% |
SMALL-CAP | ||||||||
HCCI | 800.3M | 763.4M | -5.53% | 29.23% | 9.44 | 1.05 | 38.98% | 39.07% |
PESI | 148.8M | 74.8M | 35.08% | 95.60% | -51.58 | 1.99 | 15.11% | -592.15% |
AWX | 10.7M | 85.2M | -8.70% | -14.86% | -152.36 | 0.14 | 22.52% | -12062.50% |
CHRA | 7.3M | 318.1M | -58.03% | -48.46% | -0.22 | 0.02 | 19.84% | 22.30% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 0.7% | 2,725 | 2,705 | 2,692 | 2,650 | 2,643 |
Gross Profit | 1.6% | 1,042 | 1,026 | 1,018 | 992 | 1,000 |
S&GA Expenses | -2.5% | 865 | 888 | 928 | 992 | 983 |
EBITDA | 25.1% | 260 | 208 | 106 | 122 | - |
EBITDA Margin | 24.5% | 0.10* | 0.08* | 0.04* | 0.05* | - |
Earnings Before Taxes | 39.3% | 110 | 79.00 | 32.00 | -70.00 | -50.50 |
EBT Margin | 145.4% | 0.03* | 0.01* | -0.03* | -0.02* | - |
Interest Expenses | 6.6% | 77.00 | 73.00 | 66.00 | 66.00 | 65.00 |
Net Income | 45.0% | 82.00 | 57.00 | 8.00 | -85.90 | -67.10 |
Net Income Margin | 602.9% | 0.02* | 0.00* | -0.03* | -0.03* | - |
Free Cahsflow | 885.5% | 68.00 | 7.00 | 8.00 | 72.00 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | 0.0% | 5,332 | 5,334 | 5,341 | 5,408 | 5,477 |
Current Assets | 0.9% | 564 | 559 | 598 | 597 | 614 |
Cash Equivalents | 7.1% | 60.00 | 56.00 | 44.00 | 46.00 | 60.00 |
Net PPE | -0.4% | 713 | 716 | 712 | 720 | 713 |
Goodwill | 0.1% | 2,788 | 2,785 | 2,749 | 24.00 | 2,809 |
Liabilities | -0.8% | 2,886 | 2,910 | 3,015 | 3,054 | 3,096 |
Current Liabilities | -6.7% | 581 | 622 | 587 | 619 | 670 |
Long Term Debt | 0.2% | 1,487 | 1,484 | 1,652 | 1,676 | 1,678 |
Shareholder's Equity | 1.0% | 2,445 | 2,420 | 2,322 | 2,354 | 2,381 |
Retained Earnings | 0.8% | 1,422 | 1,411 | 1,379 | 1,351 | 1,341 |
Additional Paid-In Capital | 0.3% | 1,289 | 1,285 | 1,281 | 1,271 | 1,263 |
Accumulated Depreciation | 2.9% | 677 | 658 | 664 | 681 | 678 |
Shares Outstanding | 0.2% | 92.00 | 92.00 | 92.00 | 92.00 | 92.00 |
Minority Interest | -86.0% | 1.00 | 4.00 | 3.00 | 4.00 | 4.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | 44.1% | 289 | 200 | 144 | 135 | 202 |
Share Based Compensation | 8.4% | 27.00 | 25.00 | 28.00 | 28.00 | 27.00 |
Cashflow From Investing | 2.7% | -82.30 | -84.60 | -120 | -99.30 | -102 |
Cashflow From Financing | -82.0% | -202 | -111 | -8.00 | -46.30 | -88.40 |
86.9%
60.8%
22.7%
Y-axis is the maximum loss one would have experienced if Stericycle was unfortunately bought at previous high price.
-9.0%
-10.9%
-7.3%
-5.3%
FIve years rolling returns for Stericycle.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-22 | AMERIPRISE FINANCIAL INC | reduced | -22.37 | -4,800,740 | 10,133,300 | -% |
2023-05-18 | SkyView Investment Advisors, LLC | added | 17.33 | 11,000 | 453,000 | 0.11% |
2023-05-18 | JPMORGAN CHASE & CO | added | 42.19 | 23,933,000 | 122,466,000 | 0.01% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | added | 1.49 | -559,000 | 4,399,000 | 0.01% |
2023-05-17 | Westside Investment Management, Inc. | unchanged | - | 4,357 | 4,361 | -% |
2023-05-17 | Advisory Services Network, LLC | reduced | -7.16 | -60,002 | 258,346 | 0.01% |
2023-05-17 | KB FINANCIAL PARTNERS, LLC | added | 16.03 | 5,000 | 413,000 | 0.12% |
2023-05-17 | Thrivent Financial for Lutherans | reduced | -0.92 | -164,000 | 1,061,000 | -% |
2023-05-16 | CASTLEARK MANAGEMENT LLC | reduced | -99.37 | -6,050,510 | 33,580 | -% |
2023-05-16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | reduced | -12.83 | -64,784 | 207,366 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | price t rowe associates inc /md/ | 4.9% | 4,542,380 | SC 13G/A | |
Feb 14, 2023 | clarkston capital partners, llc | 6.87% | 6,332,330 | SC 13G | |
Feb 14, 2023 | alliancebernstein l.p. | 7.6% | 6,963,391 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.60% | 8,845,201 | SC 13G/A | |
Feb 08, 2023 | black creek investment management inc. | 5.59% | 0 | SC 13G | |
Feb 03, 2023 | blackrock inc. | 8.5% | 7,803,191 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 12.0% | 11,062,819 | SC 13G/A | |
Feb 14, 2022 | alliancebernstein l.p. | 7.4% | 6,841,439 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 9.10% | 8,358,752 | SC 13G/A | |
Feb 03, 2022 | baillie gifford & co | 4.72% | 4,337,921 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 18.60 -57.09% | 24.16 -44.27% | 29.38 -32.23% | 34.40 -20.65% | 40.84 -5.79% |
Current Inflation | 18.06 -58.34% | 23.15 -46.60% | 27.92 -35.59% | 32.49 -25.05% | 38.28 -11.70% |
Very High Inflation | 17.34 -60.00% | 21.83 -49.64% | 26.06 -39.88% | 30.07 -30.63% | 35.06 -19.12% |
Date Filed | Form Type | Document | |
---|---|---|---|
May 18, 2023 | 8-K | Current Report | |
May 17, 2023 | 3 | Insider Trading | |
May 17, 2023 | 4 | Insider Trading | |
May 17, 2023 | 4 | Insider Trading | |
May 17, 2023 | 4 | Insider Trading | |
May 17, 2023 | 4 | Insider Trading | |
May 17, 2023 | 4 | Insider Trading | |
May 17, 2023 | 4 | Insider Trading | |
May 17, 2023 | 4 | Insider Trading | |
May 17, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-05-01 | Rogers Kurt | sold (taxes) | -192,813 | 45.55 | -4,233 | evp & general counsel |
2023-05-01 | Rogers Kurt | acquired | - | - | 11,068 | evp & general counsel |
2023-04-14 | Weisman Michael | acquired | - | - | 333 | evp corp ethics and compliance |
2023-04-14 | Weisman Michael | sold (taxes) | -4,116 | 42.00 | -98.00 | evp corp ethics and compliance |
2023-04-01 | Rogers Kurt | sold (taxes) | -109,374 | 43.61 | -2,508 | evp & general counsel |
2023-04-01 | Rogers Kurt | acquired | - | - | 8,559 | evp & general counsel |
2023-03-15 | Rogers Kurt | sold (taxes) | -33,314 | 42.82 | -778 | evp & general counsel |
2023-03-15 | White Stephen Cory | acquired | - | - | 2,409 | evp & chief commercial officer |
2023-03-15 | Weisman Michael | sold (taxes) | -19,397 | 42.82 | -453 | evp corp ethics and compliance |
2023-03-15 | Culotta Dominic | sold (taxes) | -22,609 | 42.82 | -528 | evp engineering |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Revenues | $ 684.3 | $ 664.2 |
Cost of revenues | 423.3 | 419.7 |
Gross profit | 261.0 | 244.5 |
Selling, general and administrative expenses | 216.0 | 238.6 |
Divestiture losses, net | 5.0 | 0.0 |
Income from operations | 40.0 | 5.9 |
Interest expense, net | (20.4) | (16.3) |
Other income (expense), net | 0.2 | (0.8) |
Income (Loss) before income taxes | 19.8 | (11.2) |
Income tax expense | (8.5) | (2.9) |
Net income (loss) | 11.3 | (14.1) |
Net income attributable to noncontrolling interests | (0.1) | (0.1) |
Net income (loss) attributable to Stericycle, Inc. common shareholders | $ 11.2 | $ (14.2) |
Income (Loss) per common share attributable to Stericycle, Inc. common shareholders: | ||
Basic (in dollars per share) | $ 0.12 | $ (0.15) |
Diluted (in dollars per share) | $ 0.12 | $ (0.15) |
Weighted average number of common shares outstanding: | ||
Basic (in shares) | 92.3 | 92.0 |
Diluted (in shares) | 92.7 | 92.0 |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 60.0 | $ 56.0 |
Accounts receivable, less allowance for doubtful accounts of $50.2 in 2023 and $53.3 in 2022 | 419.5 | 414.5 |
Prepaid expenses | 34.7 | 33.2 |
Other current assets | 49.5 | 55.0 |
Total Current Assets | 563.7 | 558.7 |
Property, plant and equipment, less accumulated depreciation of $677.1 in 2023 and $657.7 in 2022 | 713.0 | 715.7 |
Operating lease right-of-use assets | 414.7 | 398.9 |
Goodwill | 2,787.8 | 2,784.9 |
Intangible assets, less accumulated amortization of $853.1 in 2023 and $823.3 in 2022 | 784.8 | 811.1 |
Other assets | 68.0 | 64.8 |
Total Assets | 5,332.0 | 5,334.1 |
Current Liabilities: | ||
Current portion of long-term debt | 16.2 | 22.3 |
Bank overdrafts | 2.4 | 2.9 |
Accounts payable | 195.3 | 213.5 |
Accrued liabilities | 220.7 | 244.1 |
Operating lease liabilities | 95.4 | 91.2 |
Other current liabilities | 50.5 | 47.9 |
Total Current Liabilities | 580.5 | 621.9 |
Long-term debt, net | 1,486.5 | 1,484.0 |
Long-term operating lease liabilities | 340.2 | 329.0 |
Deferred income taxes | 431.8 | 427.0 |
Long-term income taxes payable | 11.4 | 11.8 |
Other liabilities | 35.6 | 35.9 |
Total Liabilities | 2,886.0 | 2,909.6 |
Commitments and contingencies | ||
EQUITY | ||
Common stock (par value $0.01 per share, 120.0 shares authorized, 92.4 and 92.2 issued and outstanding in 2023 and 2022, respectively) | 0.9 | 0.9 |
Additional paid-in capital | 1,289.2 | 1,285.4 |
Retained earnings | 1,422.0 | 1,410.8 |
Accumulated other comprehensive loss | (266.7) | (276.9) |
Total Stericycle, Inc.’s Equity | 2,445.4 | 2,420.2 |
Noncontrolling interests | 0.6 | 4.3 |
Total Equity | 2,446.0 | 2,424.5 |
Total Liabilities and Equity | $ 5,332.0 | $ 5,334.1 |